期刊文献+

我院2011年~2012年抗肿瘤药物注射剂的用药分析 被引量:2

Utilization of Injectable Antineoplastics in Our Hospital between 2011 and 2012
下载PDF
导出
摘要 目的分析与评价苏州大学附属第一医院抗肿瘤药物注射剂的使用情况。方法采用金额排序法和用药频度(DDDs)分析法对该院2011年~2012年抗肿瘤药物注射剂的使用情况进行统计分析。结果该院注射用抗肿瘤药物的销售金额呈现快速的上升趋势;各类药物的整体销售金额排序没有变化;植物来源的抗肿瘤药及其衍生物和其他抗肿瘤药及辅助治疗药的销售金额在销售总金额中占据较大比例。结论该院注射用抗肿瘤药物的使用较为稳定,同时新型抗肿瘤药物在临床上的应用发展迅速。 Objective To analyze and evaluate the utilization of injectable antineoplastics in the First Affiliated Hospital of Soochow University.Methods Amount ranking method and defined daily dose(DDDs) method were used to conduct statistical analysis of utilization of injectable antineoplastics in our hospital between 2011 and 2012.Results The consumption sum of injectable antineoplastics between 2011 and 2012 showed a fast upward trend.The ranking of overall consumption sum of all kinds of drugs didn't show any change.Antineoplastics extracted from plants and their derivatives,other antineoplastics and auxiliary treatment drugs occupied a larger proportion of the consumption sum.Conclusion The utilization of injectable antineoplastics in our hospital is stable,meanwhile,the clinical application of new antineoplastics develops rapidly.
作者 徐文杰
出处 《中国血液流变学杂志》 CAS 2013年第3期564-566,共3页 Chinese Journal of Hemorheology
关键词 抗肿瘤药物注射剂 销售金额 用药频度 用药分析 injectable antineoplastics consumption sum DDDs analysis of drug utilization
  • 相关文献

参考文献3

二级参考文献23

  • 1杜海洲,宋金燕,姚春芳.国际上抗癌新药研究的概况[J].药学服务与研究,2006,6(3):186-192. 被引量:3
  • 2王艳红,马桂芝,苏彩红.紫杉醇联合用药治疗卵巢癌的疗效比较[J].解放军药学学报,2007,23(4):311-313. 被引量:7
  • 3Hegde S, Schmidt M. To Market, To Market-2007 [J]. Ann Rep Med Chem, 2008, 43: 455-497.
  • 4Hegde S, Schmidt M. To Market, To Market-2008 [J]. Ann Rep Med Chem, 2009, 44: 577-632.
  • 5Hegde S, Schmidt M. To Market, To Market-2009 [J]. Ann Rep Med Chem, 2010, 45: 467-537.
  • 6Graul AI, Sorbera L, Pina P, et al. The year's new drugs & biologics-2009[J]. Drug News Perspect, 2010, 23 (1) : 7-36.
  • 7Cortes J, Baselga J. Targeting the microtubules in breast cancer beyond taxanes: The epothilones[J]. Oncologist, 2007, 12 (3) : 271-280.
  • 8Carter N J, Keam S J. Trabectedin-A review of its use in the management of soft tissue sarcoma and ovarian cancer[J]. Drugs, 2007, 67 (15) : 2257-2276.
  • 9Kuritzkes D, Kar S, Kirkpatrick P. Fresh from the pipeline - Maraviroe [J]. Nat Rev Drug Dis, 2008, 7 (1) : 15-16.
  • 10Deeks SG, Kar S, Gubernick SI, et al. Raltegravir[J]. Nat Rev Drug Dis, 2008, 7 (2): 117-118.

共引文献1

同被引文献28

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部